FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230587530> ?p ?o ?g. }

• W4230587530 endingPage "327" @default.
• W4230587530 startingPage "321" @default.
• W4230587530 abstract "Background: Several types of oral antidiabetic drugs (OADs), with or without insulin, may be used to achieve glycemic control in patients with type 2 diabetes mellitus (T2DM). However, real-life studies assessing diabetes treatments in Morocco are rare. Our aim was to assess the efficacy of various antidiabetic treatment regimens to achieve glycemic control in patients with uncontrolled T2DM, to determine the factors associated with a lack of glycemic control and to compare the clinical outcome after 26 weeks of treatment in a real-life setting. Methods: This prospective, observational study was carried out on 1,377 patients with uncontrolled T2DM in 139 Moroccan centers. Three groups of patients were defined according to the type of treatment: group 1: metformin and/or sulfonylurea only; group 2: metformin and/or sulfonylurea + insulin prior to inclusion; and group 3: metformin and/or sulfonylurea + started on insulin at or after inclusion. Clinical data including glycated hemoglobin (HbA1c), fasting blood glucose (FBG), blood pressure and weight were recorded at inclusion and after 3 and 6 months of treatment. Results: Mean HbA1c decreased from 9.7±1.8% at baseline to 7.5±1.2% at week-26 follow-up (P < 0.001) and the proportion of patients with controlled glycemia (HbA1c < 7%) increased from 10.8% at 12 weeks to 32.4% after 26 weeks of treatment (P < 0.001). Mean decreases in HbA1c at 26 weeks were: -1.8% in group 1 (P < 0.001), -2.7% in group 2 (P < 0.001) and -2.1% in group 3 (P < 0.001). Lack of glycemic control was related to non-observance of lifestyle recommendations, lack of treatment efficacy, poor treatment compliance and absence of diabetes education. Uncontrolled glycemia was significantly associated with obesity, hypertension, dyslipidemia, use of one OAD only and no insulin therapy. Mean weight of all patients decreased over the 26-week period, irrespective of treatment regimen. Conclusion: In a Moroccan primary care setting, observed treatment of T2DM with lifestyle recommendation, metformin, sulfolylurea and insulin was associated with improvement of glycemic control without weight gain. J Endocrinol Metab. 2015;5(6):321-327 doi: http://dx.doi.org/10.14740/jem314w" @default.
• W4230587530 created "2022-05-11" @default.
• W4230587530 creator A5025677569 @default.
• W4230587530 creator A5040582115 @default.
• W4230587530 creator A5041091380 @default.
• W4230587530 creator A5056012235 @default.
• W4230587530 creator A5056346599 @default.
• W4230587530 creator A5087601417 @default.
• W4230587530 creator A5088867967 @default.
• W4230587530 date "2015-01-01" @default.
• W4230587530 modified "2023-09-25" @default.
• W4230587530 title "Observational Study of Patients in Morocco With Uncontrolled Type 2 Diabetes Treated With Metformin and/or Sulfonylurea With or Without Insulin" @default.
• W4230587530 doi "https://doi.org/10.14740/jem314w" @default.
• W4230587530 hasPublicationYear "2015" @default.
• W4230587530 type Work @default.
• W4230587530 citedByCount "0" @default.
• W4230587530 crossrefType "journal-article" @default.
• W4230587530 hasAuthorship W4230587530A5025677569 @default.
• W4230587530 hasAuthorship W4230587530A5040582115 @default.
• W4230587530 hasAuthorship W4230587530A5041091380 @default.
• W4230587530 hasAuthorship W4230587530A5056012235 @default.
• W4230587530 hasAuthorship W4230587530A5056346599 @default.
• W4230587530 hasAuthorship W4230587530A5087601417 @default.
• W4230587530 hasAuthorship W4230587530A5088867967 @default.
• W4230587530 hasBestOaLocation W42305875301 @default.
• W4230587530 hasConcept C126322002 @default.
• W4230587530 hasConcept C134018914 @default.
• W4230587530 hasConcept C23131810 @default.
• W4230587530 hasConcept C2777180221 @default.
• W4230587530 hasConcept C2777538456 @default.
• W4230587530 hasConcept C2778854520 @default.
• W4230587530 hasConcept C2779306644 @default.
• W4230587530 hasConcept C2780323712 @default.
• W4230587530 hasConcept C2780473172 @default.
• W4230587530 hasConcept C2910068830 @default.
• W4230587530 hasConcept C555293320 @default.
• W4230587530 hasConcept C71924100 @default.
• W4230587530 hasConcept C90924648 @default.
• W4230587530 hasConceptScore W4230587530C126322002 @default.
• W4230587530 hasConceptScore W4230587530C134018914 @default.
• W4230587530 hasConceptScore W4230587530C23131810 @default.
• W4230587530 hasConceptScore W4230587530C2777180221 @default.
• W4230587530 hasConceptScore W4230587530C2777538456 @default.
• W4230587530 hasConceptScore W4230587530C2778854520 @default.
• W4230587530 hasConceptScore W4230587530C2779306644 @default.
• W4230587530 hasConceptScore W4230587530C2780323712 @default.
• W4230587530 hasConceptScore W4230587530C2780473172 @default.
• W4230587530 hasConceptScore W4230587530C2910068830 @default.
• W4230587530 hasConceptScore W4230587530C555293320 @default.
• W4230587530 hasConceptScore W4230587530C71924100 @default.
• W4230587530 hasConceptScore W4230587530C90924648 @default.
• W4230587530 hasIssue "6" @default.
• W4230587530 hasLocation W42305875301 @default.
• W4230587530 hasOpenAccess W4230587530 @default.
• W4230587530 hasPrimaryLocation W42305875301 @default.
• W4230587530 hasRelatedWork W1996010611 @default.
• W4230587530 hasRelatedWork W2072752555 @default.
• W4230587530 hasRelatedWork W2083441169 @default.
• W4230587530 hasRelatedWork W2108456334 @default.
• W4230587530 hasRelatedWork W2120212319 @default.
• W4230587530 hasRelatedWork W2211602199 @default.
• W4230587530 hasRelatedWork W2515692884 @default.
• W4230587530 hasRelatedWork W2765236233 @default.
• W4230587530 hasRelatedWork W3036676782 @default.
• W4230587530 hasRelatedWork W4287108513 @default.
• W4230587530 hasVolume "5" @default.
• W4230587530 isParatext "false" @default.
• W4230587530 isRetracted "false" @default.
• W4230587530 workType "article" @default.